[ad_1]
The United States government decided on Saturday that only one Johnson & Johnson (J&J) coronavirus vaccine would be produced at the Baltimore pharmaceutical plant, where 15 million doses of this vaccine were lost after its raw material was replaced by AstraZeneca raw material due to human error. .
Emergent BioSolution Pharmaceutical Plant in Baltimore revealed the need to replace raw material on April 1 after a shipment from J&J stopped during quality control.
The US government feared that the incident would erode confidence in the two vaccines, so it decided that from now on only US J&J vaccines would be produced there.The British-Swedish company AstraZeneca is in talks with the United States government to find new production capacity.
Unlike the vaccine, developed jointly by AstraZeneca and the University of Oxford, the J&J vaccine consists of a single dose and has been approved for a third emergency use in the United States. The AstraZeneca vaccine has not yet been approved.
[ad_2]
